GEA Farm Technologies, Inc., a subsidiary of GEA Group AG, is an American company located in Naperville, IL, involved in farm machinery and equipment.

Manufactures healthcare equipment

Epiontis was founded in 2003 by Dr. Sven Olek and Dr. Ulrich Hoffmueller. The company is headquartered in the Science- and Technology Park Adlershof in the south of Berlin, Germany - a leading site for Biotechnology and Life Sciences in Berlin-Brandenburg. Epiontis offers worldwide services. Using a novel molecular diagnostics technology, Epiontis offers an immune cell monitoring service as well as customized development of epigenetic assays. Epiontis' epigenetic assay format allows the identification and quantification of any cell type with accuracy and technical ease. The main field of use is the monitoring of immune cells in research and clinical studies for autoimmune and infectious diseases or cancer. Here, they offer a portfolio of established assays for immune cells. Examples include diagnostic assays for regulatory T cells (Tregs) and tumor infiltrating lymphocytes, with many other epigenetic assays under development. In addition, they develop customized immunmonitoring essays that serve your needs.

ISARIC - International Severe Acute Respiratory and Emerging Infection Consortium - is a global initiative aiming to ensure that clinical researchers have the open access protocols and data-sharing processes needed to facilitate a rapid response to emerging diseases that may turn into epidemics or pandemics.

Veterix Ltd. had developed cattle health diagnostic systems for the industry of beef livestock and dairy cattle. The system was consisted of a telemetric monitoring system based on state-of-the-art wireless communications technology and digital signal processing in order to provide automatic and continuous monitoring and control of physiological parameters of each animal. The company was founded by Eliav Tahar in 2004 and was headquartered in Or Akiva, Israel.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Shenzhen Ruilin Pharmaceutical Co., Ltd., established on 2001-09-07, Business scope includes general business items:Medical Devices and Equipment,Technology development of healthcare equipment,technical consulting,Technology Transfer and Technical Services;(Commodities that do not involve state trade management,Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations);drug,Pharmaceutical preparations and reagents,Research and development of health food(Not included<Regulations on the Protection and Management of Wild Medicinal Resources>and<List of Rare and Endangered Plants in China>processing of Chinese herbal medicines,Steaming of Chinese Herbal Pieces,saute,broil,Application of calcining and other processing technologies and production of secret prescriptions of Chinese patent medicines,Restricted and prohibited projects such as research and development of rare and unique precious varieties in China,Involving license management and other special regulation management,Operate only after obtaining a license);Research and development of biotechnology(Does not contain human stem cells,Development and application of genetic diagnosis and treatment technology,Rare and unique precious fine varieties in China,crop,Breeding livestock,Restricted and prohibited items such as selection and breeding of genetically modified aquatic products,Involving license management and other special regulation management,Operate only after obtaining a license);daily necessities,cosmetic,Medical Devices and Equipment,Wholesale and retail of health care equipment,Import and export and related supporting business(involved in state trade,quota,Commodities stipulated in licenses and special management,According to the relevant regulations of the state to apply for operation);Business Consulting,marketing planning,Cultural exchange event planning,Construction of conference booths related to the pharmaceutical industry,Exhibition Planning(Does not involve special management measures for foreign investment access);Leasing and door-to-door repair of medical equipment;Wholesale and retail of electronic products;Realtor;Pharmaceutical commissioned production.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Chinese patent medicine,Chemical API,Accessories,medical supplements,Chemicals,Antibiotic API,antibiotic preparation,Wholesale of biochemical drugs;Pre-packaged food(Without reheating),dairy products(Does not contain infant formula),Healthy food(Auxiliary hypoglycemic),Health food raw materials,Wholesale of food raw materials,Import and export and related supporting business;Prepackaged food sales(Does not contain refrigerated frozen food);special food sales(Does not contain drugs),Production and sales of health food;Ikind,Class II,Wholesale and retail of Class III medical devices,Import and export and related supporting business;pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Avaris was founded in 2001 by research teams at the Karolinska Institute and Karolinska Innovations AB. The company is based on four proprietary technology platforms within cell and gene therapy.\nAvaris drives the research development and commercialization of new therapies in close collaboration with the founders, research teams, and strategic partners. The company is well positioned in cell and gene therapy field for chronic infections, cancer and inherited diseases.\nAvaris vision is to become the number one supplier of individualized cell and gene therapy treatments in northern Europe. In order to reach this goal it is exploring possibilities to acquire, or in license cell therapy technologies that complement the in house growth. Avaris is also open to partnering possibilities.

TechMix is an industry-acknowledged leader in hydration & stress event solutions for production animals in Stewart, Minnesota.

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

Bayer CropScience NV, part of Bayer AG, is a Belgian company located in Diegem. The firm wholesales fertilizers and other agrochemical products. It was founded in 1972. Sylvain Moissionnier has been the CEO since 2020.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.